Epilepsy GTx
HealthcareBiotech & Pharma
HQ: Canterbury, United Kingdom
Investors: 1
Providing seizure freedom for patients with focal refractory epilepsy
Investors (1)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| XGen Venture SGR | Current | - | - | Website |
Signals (1)
InvestmentXGen Venture SGR
2026-02-08New portfolio investment: Epilepsy GTx in Life Sciences sector
Source: XGen Venture SGR